WallStSmart

Amrize Ltd (AMRZ)vsSherwin-Williams Co (SHW)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Sherwin-Williams Co generates 101% more annual revenue ($23.94B vs $11.91B). SHW leads profitability with a 10.9% profit margin vs 9.7%. AMRZ appears more attractively valued with a PEG of 1.42. SHW earns a higher WallStSmart Score of 56/100 (C).

AMRZ

Hold

49

out of 100

Grade: D+

Growth: 4.0Profit: 5.0Value: 5.7Quality: 5.0
Piotroski: 2/9Altman Z: 1.61

SHW

Buy

56

out of 100

Grade: C

Growth: 5.3Profit: 7.5Value: 5.3Quality: 4.0
Piotroski: 4/9Altman Z: 1.54
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for AMRZ.

SHWUndervalued (+4.8%)

Margin of Safety

+4.8%

Fair Value

$320.70

Current Price

$300.09

$20.61 discount

UndervaluedFair: $320.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AMRZ1 strengths · Avg: 8.0/10
Price/BookValuation
2.3x8/10

Reasonable price relative to book value

SHW2 strengths · Avg: 9.5/10
Return on EquityProfitability
58.7%10/10

Every $100 of equity generates 59 in profit

Market CapQuality
$73.12B9/10

Large-cap with strong market position

Areas to Watch

AMRZ4 concerns · Avg: 4.0/10
P/E RatioValuation
25.2x4/10

Moderate valuation

Revenue GrowthGrowth
4.7%4/10

4.7% revenue growth

EPS GrowthGrowth
3.6%4/10

3.6% earnings growth

Altman Z-ScoreHealth
1.614/10

Distress zone — elevated risk

SHW4 concerns · Avg: 4.0/10
PEG RatioValuation
2.294/10

Expensive relative to growth rate

P/E RatioValuation
28.5x4/10

Moderate valuation

Price/BookValuation
16.6x4/10

Trading at 16.6x book value

Altman Z-ScoreHealth
1.544/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : AMRZ

The strongest argument for AMRZ centers on Price/Book. PEG of 1.42 suggests the stock is reasonably priced for its growth.

Bull Case : SHW

The strongest argument for SHW centers on Return on Equity, Market Cap.

Bear Case : AMRZ

The primary concerns for AMRZ are P/E Ratio, Revenue Growth, EPS Growth.

Bear Case : SHW

The primary concerns for SHW are PEG Ratio, P/E Ratio, Price/Book. Debt-to-equity of 3.11 is elevated, increasing financial risk.

Key Dynamics to Monitor

SHW is growing revenue faster at 6.8% — sustainability is the question.

SHW generates stronger free cash flow (800,000), providing more financial flexibility.

Monitor BUILDING MATERIALS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

SHW scores higher overall (56/100 vs 49/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Amrize Ltd

BASIC MATERIALS · BUILDING MATERIALS · USA

Amrize Ltd (AMRZ) is an innovative technology company at the forefront of the digital health and wellness sector, dedicated to transforming healthcare delivery through advanced technologies and data-driven solutions. With a strong focus on improving patient outcomes and enhancing accessibility, Amrize invests significantly in research and development to meet the growing demand for scalable health innovations. Its strategic initiatives and diverse product offerings position the company as a key player in modern healthcare transformation, presenting a compelling opportunity for institutional investors in a rapidly evolving market.

Visit Website →

Sherwin-Williams Co

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Sherwin Williams Company is a Cleveland, Ohio based company in the paint and coating manufacturing industry. The company primarily engages in the manufacture, distribution, and sale of paints, coatings, floorcoverings, and related products to professional, industrial, commercial, and retail customers primarily in North and South America and Europe.

Want to dig deeper into these stocks?